Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,067 JPY | +5.96% | +86.09% | +52.42% |
Jun. 17 | SanBio’s Attributable Losses Narrows in Fiscal Three Months | MT |
Jun. 13 | Approval Pending for SanBio's Brain Injury Treatment Candidate as Deliberations Continue | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.42% | 500M | |
+14.84% | 122B | |
+18.31% | 113B | |
+3.61% | 22.66B | |
-18.26% | 21.34B | |
-41.55% | 16.92B | |
-14.23% | 16.68B | |
-16.03% | 16.61B | |
-0.68% | 13.62B | |
+21.87% | 11.04B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March